Medicenna is a clinical stage, privately held, immuno-oncology company.
Medicenna Therapeutics has raised $4.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Medicenna Therapeutics's investors include RA Capital Management, Cancer Prevention and Research Institute of Texas.
Medicenna Therapeutics is headquartered in Toronto, Canada.
Medicenna is a clinical stage, privately held, immuno-oncology company.
Medicenna Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Medicenna Therapeutics — Funding & Investors." VCBacked, June 26, 2026, https://www.vcbacked.co/company/medicenna-therapeutics. Accessed August 15, 2026.
VCBacked. (2026). Medicenna Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/medicenna-therapeutics
{{cite web |title=Medicenna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/medicenna-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated